Professional Summary
Professional Overview
Michael Boyce-Jacino is an experienced life sciences executive with a track record of success in the biotechnology and medical device industries. As the CEO of Aptatek Biosciences, he leads a team focused on developing innovative diagnostic solutions. Additionally, he serves as the Team Lead for the NIH RADx Tech program and the Chief Scientific Officer at Eterna BioCapital, leveraging his extensive expertise in genomics, molecular biology, and product development.
Experience Summary
Current Roles
CEO, Aptatek Biosciences (2016-Present): Responsible for the overall strategic direction and operational management of the company, leading the development and commercialization of advanced diagnostic technologies. Under his leadership, Aptatek has secured significant funding and partnerships, positioning the company as a leader in its field.
Team Lead, NIH RADx Tech (2020-Present): Serving as the team lead for this National Institutes of Health (NIH) initiative, Michael oversees the rapid development, validation, and deployment of novel COVID-19 testing technologies to address the pandemic.
Chief Scientific Officer, Eterna BioCapital (2016-Present): In this role, Michael provides strategic guidance and scientific expertise to support the investment firm's portfolio of biotechnology and life sciences companies.
Career Progression
Executive Director and Head, US Operations, NetScientific, Plc (2010-2016): Played a key role in expanding the company's presence in the US market, leading the development and commercialization of several medical technologies.
CEO, BioNano Genomics (BioNanomatrix) (2004-2010): Spearheaded the growth and development of this genomics research company, driving the commercialization of innovative DNA analysis platforms.
Vice President, Genomics, Beckman Coulter (2002-2004): Responsible for leading the company's genomics division, overseeing the development and launch of new products in the field of molecular diagnostics.
Chief Scientific Officer, Orchid Biosciences (1998-2002): Served as the chief scientific officer, where he played a pivotal role in advancing the company's genetic testing and forensic science technologies.
Academic Background
Michael holds a Ph.D. in Molecular Biology from the University of California, Berkeley, and a B.S. in Biochemistry from the University of California, Los Angeles. His graduate research focused on the development of novel DNA sequencing and analysis methods, laying the foundation for his subsequent career in the life sciences industry.
Areas of Expertise
- Biotechnology and medical device product development
- Genomics, molecular biology, and bioinformatics
- Diagnostic technology innovation and commercialization
- Scientific research and product development management
- Strategic leadership and business development
Professional Impact
Throughout his career, Michael has made significant contributions to the advancement of diagnostic and genomic technologies. His work has resulted in the development and commercialization of several groundbreaking products, and he has played a key role in securing funding and partnerships to support the growth of the companies he has led.
Conclusion
Michael Boyce-Jacino is a seasoned life sciences executive with a proven track record of driving innovation and delivering operational success. With his deep scientific expertise, strong leadership skills, and strategic vision, he is well-positioned to continue making a meaningful impact in the biotechnology and medical device industries.
